A Multi-centre, Double-blind, Parallel-group, Randomized Controlled Study to Investigate the Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Alzheimer Disease
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006868/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study is designed to compare the effects of 4 different doses of orally administered BI
409306 to placebo in patients with Alzheimers Disease
提供机构：
Vivli
创建时间：
2021-04-14
